Condition: Epithelial Ovarian Cancer · Fallopian Tube Cancer · Primary Peritoneal Carcinoma · Sponsor: Shanghai Gynecologic Oncology Group
The purpose of this study is to evaluate the safety and the effectiveness of hepato-celiac lymphadenectomy in the treatment of primarily diagnosed advanced epithelial ovarian cancer and platinum-sensitive recurrent ovarian cancer.
This description comes directly from the study's public registry record.
Libing Xiang · 862164041990 · xiang.libing@zs-hospital.sh.cn
Rong Jiang · 86 21 64041990 · jiang.rong@zs-hospital.sh.cn
Always discuss trial participation with your own doctor first.
| Zhongshan Hospital, Fudan University | Shanghai, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05236686